stock-detail (CALA)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/13/2017 06:17 am

4/13/2017 06:17 am

4/13/2017 06:17 am

4/13/2017 06:17 am

4/13/2017 06:17 am

Calithera Biosciences to Present at the 16th Annual Needham Health Care Conference

3/29/2017 11:00 am

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 29, 2017-- Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor ...

Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement of Pharmacokinetic and Pharmacodynamic Goals in Phase 1 Study

3/28/2017 11:00 am

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 28, 2017-- Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor ...

Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

3/27/2017 08:00 pm

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 27, 2017-- Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor ...

Calithera Biosciences, Inc. Prices Public Offering of 6,830,000 shares of Common Stock

3/22/2017 11:00 am

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 22, 2017-- Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor ...

Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

3/20/2017 08:00 pm

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 20, 2017-- Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor ...